Appendix Table A. Movement in the Intensity of Physician-Stated A1C Goals among the Total Population and Stratified by Model Predicted Life Expectancy.
Intervention (n=75) | Control (n=25) | P valueb | ||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Upper A1c Goalc | Pre | Post | P value | Pre | Post | P value | ||
|
||||||||
Total population, %a | ≤7.0 | 49 | 56 | 0.34 | 68 | 60 | 0.51 | 0.30 |
≥7.1 | 51 | 44 | 32 | 40 | ||||
| ||||||||
Model predicted life expectancyd | ||||||||
| ||||||||
Sample size | 22 | 9 | ||||||
|
||||||||
LE ≤5 | ≤7.0 | 41 | 41 | 1.00 | 67 | 56 | 0.57 | 0.65 |
≥7.1 | 59 | 59 | 33 | 44 | ||||
| ||||||||
Sample size | 53 | 16 | ||||||
|
||||||||
LE >5 | ≤7.0 | 53 | 62 | 0.27 | 69 | 63 | 0.68 | 0.37 |
≥7.1 | 47 | 38 | 31 | 38 |
Values reported are the percentage of patients, unless otherwise stated in the table.
All reported P values are from generalized linear mixed models that account for clustering by physician.
An intensive goal was defined as an A1C goal ≤7.0. A moderate goal was defined as an A1C goal ≥7.1.
Model predicted life expectancy was taken from the life expectancy predicted by the embedded prediction model in the Personal DC tool. Control patients were also run through the model to generate model predicted life expectancy for result comparison.